Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand

NCT00672412 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

42

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: GPO-Vir Z30 tablet
DRUG: Lamivudine
DRUG: Nevirapine
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]